DOD Melanoma Idea Award | W81XWH 21 MRP IA

FAQs: DoD Melanoma Research Program (MRP) FY21 Idea Award

What is the DoD MRP FY21 Idea Award?

The Department of Defense (DoD) Melanoma Research Program (MRP) FY21 Idea Award is a competitive research funding opportunity intended to spark genuinely new directions in melanoma science. It is designed to support bold, early-stage ideas that are still unproven but could significantly change how melanoma is understood, detected, or treated.

What is the main goal of this funding opportunity?

The central aim is to enable innovative, exploratory, and high-risk/potentially high-reward melanoma research projects that introduce new concepts, theories, methods, or research paradigms. The program is specifically looking for originality and transformative potential rather than routine or incremental advances.

Why is the Department of Defense funding melanoma research?

The program highlights that progress in melanoma research and clinical care within the Military Health System (MHS) directly benefits active-duty Service Members, Veterans, and other military beneficiaries. Those advances may also benefit the broader American public.

What kinds of projects are a strong fit for the Idea Award?

Projects that propose genuinely innovative and unproven ideas with the potential to open new lines of investigation in melanoma. The opportunity emphasizes work that challenges prevailing assumptions, introduces a new way of thinking, or approaches persistent problems from a fresh angle.

Does the project need to be hypothesis-driven?

Not necessarily. Proposals may be hypothesis-driven or hypothesis-generating and can be exploratory in nature. However, they must include a strong scientific rationale and present a clear study design and analysis plan that demonstrate the work can be executed and interpreted rigorously.

What does "high-risk/potentially high-reward" mean in this program?

It refers to research that is early-stage and not yet established, where outcomes are uncertain (high risk), but where success could lead to major advances or a shift in understanding, detection, or treatment of melanoma (high reward).

What types of proposals are discouraged or considered out of scope?

The program explicitly discourages proposals that mainly extend previously published findings, continue an existing research trajectory, or represent incremental progress that could be described as the "next logical step." It is also not intended for routine follow-on studies that primarily refine current approaches.

Can I adapt an approach used in another cancer type and apply it to melanoma?

Simply shifting an existing technique or question from another cancer type into melanoma is not considered sufficiently innovative under this mechanism unless the proposal includes a truly creative conceptual leap and transformative originality.

Is the topic limited specifically to melanoma?

Yes. The topic scope is tightly focused on melanoma.

Are studies on non-melanoma skin cancers allowed?

No. Studies centered on non-melanoma skin cancers are not allowed under the FY21 MRP Idea Award. Proposed research must clearly and directly address melanoma rather than other skin cancer types.

Who administers this funding opportunity?

The opportunity is administered by the Department of Defense, Department of the Army, through the U.S. Army Medical Research Acquisition Activity (USAMRAA).

What is the Funding Opportunity Number (FON) for this award?

The Funding Opportunity Number is W81XWH-21-MRP-IA.

What CFDA number is associated with this opportunity?

The opportunity is categorized under CFDA 12.420.

What type of funding mechanism is used (grant vs. cooperative agreement)?

Awards could be made as either grants or cooperative agreements.

Who was eligible to apply?

Eligibility was described as unrestricted, meaning applications were generally open to a wide range of organizations and entities, subject to any additional eligibility notes in the full announcement.

When was the opportunity posted?

The opportunity was posted on May 7, 2021.

What was the application deadline?

The original application deadline was September 28, 2021.

How many awards were expected?

The program anticipated making approximately 10 awards.

What was the maximum award amount (ceiling)?

The award ceiling was shown as 0 in the source data, which typically indicates the ceiling was not specified in that particular summary field. The actual ceiling would need to be confirmed in the full solicitation materials.

Is this considered discretionary funding?

Yes. The opportunity was categorized as discretionary funding within science and technology and other research and development activities.

Does the Idea Award support incremental improvements to existing melanoma approaches?

No. The program emphasizes that proposed work should do more than refine current approaches. It should introduce a new way of thinking, challenge prevailing assumptions, or provide a fresh angle on a persistent melanoma problem.

What level of detail is expected in the research plan?

Even though the award supports early-stage and exploratory research, the proposal still needs a strong scientific rationale, a clear study design, and an analysis plan to show the work can be carried out and interpreted rigorously.